CMND logo

CMNDClearmind Medicine Inc

$3.23
$0.19
(5.61%)
Today
Closed $3.20
$0.0252
(0.79%)
After Hours
Updated: 06:23 PM EDT
Mkt Cap$3.45M
Vol118,038.00
News
all
press releases
Biotech Stocks Are Loading Up on Major 2026 Catalysts and Wall Street Is Watching
Investors continue to focus on companies capable of generating meaningful clinical milestones, regulatory achievements, and commercial opportunities in large underserved markets. Several small-cap healthcare names now have potentially market-moving events scheduled throughout the remainder of 2026, positioning them among closely watched stocks in the biotech and healthcare sectors. $BCDA, $NTHI, $MTVA, $BGMS, $CMND
24-7 Market News
News Placeholder
More News
News Placeholder
Why Did CMND Stock Jump 40% Today?
Clearmind Medicine announced that it filed a patent in Japan for its proprietary non-hallucinogenic psychedelic-based therapy for depression.
Stocktwits
News Placeholder
Why Is Clearmind Medicine Stock Sliding On Wednesday?
Clearmind Medicine Inc. (NYSE: CMND) faces a price correction Wednesday following a massive rally. Read more on the impact of CMND-100 trial results and new executive orders.read more...
Benzinga
News Placeholder
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric Biosciences, Fitness Champs, Clearmind Medicine surge.read more...
Benzinga
News Placeholder
CMND Stock Set For Biggest Intraday Gains In Over Three Years — Here’s Why Retail Is Eyeing Further Upside
Psychedelic biotech stocks rallied after a new executive order fast-tracked drug approvals and funding.
Stocktwits
News Placeholder
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine
CBS News reported on Thursday that President Trump is expected to sign the executive order as soon as this week.
Stocktwits
News Placeholder
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss? Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment...
PR Newswire
News Placeholder
Polyrizon Partners With Clearmind To Advance Intranasal MEAI For CNS Disorders
(RTTNews) - Clearmind Medicine (CMND) announced that it has entered into a development agreement with Polyrizon to create a proprietary intranasal formulation of MEAI, a non-hallucinogenic...
Nasdaq News: Markets
News Placeholder
Why Did Clearmind Medicine Shares Plunge 29% After Hours?
Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock split.read more...
Benzinga
News Placeholder
Penny Stocks To Add to Your Watchlist - November 13th
Leap Therapeutics, Nuvve, Bitfarms, Safe & Green, TNL Mediagene, Strive, and Clearmind Medicine are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.